Advanced Enzyme Technologies share news, announcements and annual reports
NSE: ADVENZYMESBSE: 540025Pharmaceuticals & BiotechnologySmall Cap
Advanced Enzyme Technologies Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2016 · Issue price ₹896
Last close ₹281.45up ₹17.90 (6.79%)BSE ₹281.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹263.55.
2 Nov: open ₹271.00, high ₹288.00, low ₹265.65
52-week range of traded prices to 2 Nov 2026
₹246.80Low, 26 Oct 2026₹419.00High, 11 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,084 Cr912th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.05
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,44,23328.1% delivered
Advanced Enzyme Technologies share news and announcements
743 announcements, routine notices left out, newest first. Page 6 of 15.
Mar 2023
Feb 2023
22 Feb · Analysts
20 Feb · Analysts
11 Feb · Business
11 Feb · Results
7 Feb · Analysts
Jan 2023
Dec 2022
23 Dec · Analysts
6 Dec · Legal
The exchange asked on 5 Dec 2022
Nov 2022
Oct 2022
Sep 2022
30 Sep · Issuance/changes in Capital-Others
Aug 2022
19 Aug · Meeting
Jul 2022
21 Jul · Corporate action
21 Jul · Disclosure
Jun 2022
3 Jun · Related Party Transaction
May 2022
26 May · Analysts